Patients' and dermatologists' preferences in artificial intelligence-driven skin cancer diagnostics: A prospective multicentric survey study.

Abstract

Authors

• Sarah Haggenmüller
  Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Roman C Maron
  National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
• Achim Hekler
  National Center for Tumor Diseases, Department of Translational Oncology, German Cancer Research Center, Heidelberg, Germany.
• Eva Krieghoff-Henning
  Digital Biomarkers for Oncology Group (DBO), National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Jochen S Utikal
  Department of Dermatology, Heidelberg University, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Maria Gaiser
  Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
• Verena Müller
  Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
• Sascha Fabian
  Department of Economics, University of Applied Science Neu-Ulm, Neu-Ulm, Germany.
• Friedegund Meier
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
• Sarah Hobelsberger
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.
• Frank F Gellrich
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
• Mildred Sergon
  Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
• Axel Hauschild
  Department of Dermatology, University Hospital Kiel, Kiel, Germany.
• Michael Weichenthal
  Department of Dermatology, University Hospital Kiel, Kiel, Germany.
• Lars E French
  Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.
• Lucie Heinzerling
  Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.
• Justin G Schlager
  Department of Dermatology and Allergology, Ludwig Maximilian University of Munich, Munich, Germany.
• Kamran Ghoreschi
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Max Schlaak
  Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
• Franz J Hilke
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Gabriela Poch
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Sören Korsing
  Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
• Carola Berking
  Department of Dermatology, University Hospital Munich, Ludwig Maximilian University of Munich, Munich, Germany.
• Markus V Heppt
  Department of Dermatology, University Hospital Erlangen, University of Erlangen, Erlangen, Germany.
• Michael Erdmann
  Department of Dermatology, University Hospital Erlangen, Comprehensive Cancer Center Erlangen - EMN, Friedrich-Alexander University Erlangen, Nuremberg, Germany.
• Sebastian Haferkamp
  Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
• Konstantin Drexler
  Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
• Dirk Schadendorf
  Department of Dermatology, University Hospital Essen, 45147 Essen, Germany.
• Wiebke Sondermann
  Department of Dermatology, University Hospital Essen, Essen, Germany.
• Matthias Goebeler
  Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
• Bastian Schilling
  Department of Dermatology, University Hospital Wuerzburg, Wuerzburg, Germany.
• Jakob N Kather
  Department of Gastroenterology, University Hospital RWTH Aachen, Aachen, Germany. jakob.kather@gmail.com.
• Stefan Fröhling
  National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
• Katharina Kaminski
  Melanom Info Deutschland - MID e.V., Essen, Germany.
• Astrid Doppler
  Melanom Info Deutschland - MID e.V., Essen, Germany.
• Tabea Bucher
  Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• Titus J Brinker
  National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Keywords

External Resources